title: Effects of amniotic membrane suspension in human corneal wound healing in vitro.
abstract: OBJECTIVE
  To investigate the biochemical mechanism of amniotic membrane (AM) suspension on corneal wound healing, particularly on epithelial proliferation and migration.
  
  
  METHODS
  Human corneal epithelial cells (HCECs) were cultured in media with different concentrations of AM suspension (5% and 30%), Dulbecco's Modified Eagle Medium: Nutrient Mixture F-12 (negative control), and serum containing Dulbecco's Modified Eagle Medium: Nutrient Mixture F-12 (positive control). In an effort to evaluate the migratory potential of AM, migration assays were conducted via the manual scraping of HCECs and immunocytochemical staining of cell adhesion molecules (E-cadherin). The relative expression of matrix metallopeptidase 9 (MMP9) and adhesion molecules (E-cadherin, fibronectin) was determined via reverse transcription-polymerase chain reaction (RT-PCR) and western blot analysis. The proliferative potential of AM was evaluated via a proliferation assay using 5-Bromo-2-deoxyuridine (BrdU) incorporation and western blot analysis for proliferating cell nuclear antigen (PCNA). In addition, enzyme-linked immunosorbent assay (ELISA) was used to measure the protein concentrations of mitogenic growth factors (epidermal growth factor [EGF],keratinocyte growth factor [KGF], hepatocyte growth factor [HGF], and basic fibroblast growth factor [bFGF]) in AM suspensions.
  
  
  RESULTS
  Migration assay rates were enhanced as AM concentrations increased, with statistically significant changes seen in 30% AM-treated and positive control cells, compared to negative control cells (p<0.05). RT-PCRs revealed that the expression of the MMP9 gene was upregulated by AM, and the expressions of E-cadherin and fibronectin genes were downregulated by AM. Western blot analysis demonstrated significantly higher MMP9 expression in AM-treated groups, versus significantly lower levels of E-cadherin and fibronectin expression in AM-treated groups. Immunocytochemistry showed large quantities of E-cadherin near the wound edges after 24 h of injury in the AM-treated groups. The proliferation assay showed that the BrdU positive cell counts/total cell counts (labeling index) were augmented by AM to a statistically significant degree (p<0.05 in the 30% AM and positive control groups). Western blot analysis showed that the expression cell cycle-associated protein, PCNA, increased gradually as a result of AM treatment. ELISA showed that our AM suspension contained 4 growth factors (HGF, EGF, KGF, and FGF). The amount of HGF was especially large, followed by that of EGF.
  
  
  CONCLUSIONS
  These results demonstrate that the suspension form of AM maintains its beneficial effect on corneal epithelial wound healing in vitro, and that AM suspension leads to significant increases in corneal epithelial migration and proliferation with increasing AM concentrations.
authors.affiliation: Department of Ophthalmology and Visual Science, Kangnam St. Mary's Hospital, College of Medicine, the Catholic University of Korea, Seoul, ROK.
authors.forename: Jin A
authors.initials: JA
authors.lastname: Choi
authors.forename: Hyun-Jin
authors.initials: HJ
authors.lastname: Jin
authors.forename: Samhyun
authors.initials: S
authors.lastname: Jung
authors.forename: Eunkyung
authors.initials: E
authors.lastname: Yang
authors.forename: Jun-Sub
authors.initials: JS
authors.lastname: Choi
authors.forename: So-Hyang
authors.initials: SH
authors.lastname: Chung
authors.forename: Choun-Ki
authors.initials: CK
authors.lastname: Joo
mesh_terms: D000650:Amnion / Q000166:cytology* / Q000187:drug effects; D015153:Blotting, Western; D015820:Cadherins / Q000378:metabolism; D002465:Cell Movement / Q000187:drug effects; D049109:Cell Proliferation / Q000187:drug effects; D003315:Cornea / Q000187:drug effects / Q000473:pathology*; D004847:Epithelial Cells / Q000166:cytology / Q000187:drug effects / Q000201:enzymology; D005353:Fibronectins / Q000378:metabolism; D005786:Gene Expression Regulation / Q000187:drug effects; D006801:Humans; D007150:Immunohistochemistry; D036341:Intercellular Signaling Peptides and Proteins / Q000494:pharmacology; D020780:Matrix Metalloproteinase 9 / Q000378:metabolism; D008934:Mitogens / Q000494:pharmacology; D018809:Proliferating Cell Nuclear Antigen / Q000378:metabolism; D013535:Suspensions; D014945:Wound Healing / Q000187:drug effects / Q000502:physiology*
chemical_list: D015820:Cadherins; D005353:Fibronectins; D036341:Intercellular Signaling Peptides and Proteins; D008934:Mitogens; D018809:Proliferating Cell Nuclear Antigen; D013535:Suspensions; D020780:Matrix Metalloproteinase 9